Construction of immunogens for synthetic malaria vaccines
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 153 (1), 31-38
- https://doi.org/10.1016/s0006-291x(88)81185-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- Clinical Evaluation of the Immunoadjuvant Murabutide, a Derivative of MDP, Administered with a Tetanus Toxoid VaccineThe Journal of Infectious Diseases, 1986
- Effect of Antibodies to Recombinant and Synthetic Peptides on P. falciparum Sporozoites in VitroScience, 1986
- Rationale for Development of a Synthetic Vaccine Against Plasmodium falciparum MalariaScience, 1985
- Immunogenicity of Synthetic Peptides from Circumsporozoite Protein of Plasmodium falciparumScience, 1985
- DNA Cloning of Plasmodium falciparum Circumsporozoite Gene: Amino Acid Sequence of Repetitive EpitopeScience, 1984
- Structure of the Gene Encoding the Immunodominant Surface Antigen on the Sporozoite of the Human Malaria Parasite Plasmodium falciparumScience, 1984
- Epitope specific immunity elicited by a synthetic streptococcal antigen without carrier or adjuvantBiochemical and Biophysical Research Communications, 1983
- Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptideCellular and Molecular Life Sciences, 1978
- SYNTHESIS OF SOME NEW ANALOGS OF THE IMMUNOADJUVANT GLYCOPEPTIDE MDP (N‐ACETYL‐MURAMYL‐L‐ALANYL‐D‐ISOGLUTAMINE)International Journal of Peptide and Protein Research, 1978